란셋 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of lancet Market

The global lancet market recorded steady growth in 2025, supported by the rising prevalence of diabetes and increasing demand for routine diagnostic testing. According to the report, the global lancet market size was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, exhibiting a CAGR of 10.72% during the forecast period. North America dominated the market with a 34.98% share in 2025, driven by strong adoption of advanced blood glucose monitoring devices and favorable reimbursement policies.

Lancets are small, sharp medical devices used for capillary blood sampling, primarily for blood glucose testing, hemoglobin testing, and cholesterol monitoring. These devices are widely used in hospitals, diagnostic laboratories, and home-care settings. Growing awareness regarding needle-stick injury prevention and the rising adoption of safety-engineered lancets are significantly contributing to market expansion.

Market Dynamics

Market Drivers

The rising prevalence of diabetes and chronic diseases is a key driver of the global lancet market. Lancets are extensively used by diabetic patients for daily blood glucose monitoring. According to the Institute for Health Metrics and Evaluation (June 2023), over half a billion people worldwide are living with diabetes. Additionally, increasing adoption of home-based diagnostic solutions and the preference for minimally invasive blood sampling techniques are driving demand for advanced safety lancets.

Market Restraints

The cost sensitivity of safety lancets is expected to restrain market growth, particularly in developing regions. Safety lancets are more expensive than traditional lancets, limiting their adoption in cost-conscious healthcare systems. NHS data published in October 2020 showed that safety lancets cost approximately USD 4.87-5.06 per 100 units, compared to USD 2.37-4.22 per 100 units for standard lancets, discouraging widespread adoption of advanced products.

Market Opportunities

The increasing need for home healthcare monitoring is creating lucrative growth opportunities. As more patients manage chronic conditions such as diabetes at home, demand for easy-to-use and safe blood sampling devices is rising. A study published in the Indian Journal of Medical Specialties (December 2023) indicated that 35% of patients used glucometers for self-monitoring at home, supporting increased lancet consumption.

Lancet Market Trends

Technological advancements and sustainable product designs are emerging as key trends. Manufacturers are developing ultra-fine gauge lancets (21G-30G) with spring-loaded and ergonomic mechanisms to minimize pain and improve patient comfort. Additionally, regulatory emphasis on safety-engineered sharps and growing focus on environmentally friendly designs using reduced plastic and biodegradable materials are influencing product development.

Segmentation Analysis

By Type

Based on type, the market is segmented into standard lancets, safety lancets, and specialty lancets. The safety lancets segment is projected to dominate with a 51.55% share in 2026, driven by increasing adoption among diabetic patients requiring frequent testing.

By Incision Type

The market is categorized into needle and blade lancets. The needle segment is projected to lead with a 93.65% share in 2026, owing to reduced pain, ease of use, and superior safety features.

By Age Group

Adults dominated the market with a 72.8% share in 2025 and are expected to account for 72.92% in 2026, supported by higher testing rates for diabetes and cholesterol. The pediatric segment is projected to grow at a CAGR of 10.1%.

By Gauge Size

The 23G-28G segment dominated with a 73.3% share in 2025 and 73.35% in 2026, due to optimal balance between comfort and blood flow efficiency.

By Application

Blood glucose monitoring dominated the market with a 56.3% share in 2025, supported by the increasing global diabetic population. Hemoglobin testing is expected to grow at a CAGR of 10.8%.

By Distribution Channel

Retail pharmacies dominated the market and are projected to hold a 51.9% share in 2025, driven by accessibility and bundled diabetes care offerings.

Regional Outlook

North America led the market with USD 0.81 billion in 2025 and USD 0.88 billion in 2026, supported by reimbursement policies and advanced healthcare infrastructure. Europe reached USD 0.78 billion in 2025, while Asia Pacific accounted for USD 0.62 billion. Latin America and the Middle East & Africa recorded USD 0.07 billion and USD 0.02 billion, respectively, in 2025.

Competitive Landscape

The global lancet market is highly fragmented, with key players such as BD, HTL-STREFA, Abbott, Cardinal Health, and Terumo Medical Corporation holding significant market presence. These companies focus on product innovation, capacity expansion, and geographic growth. In January 2025, BD announced investments in U.S. manufacturing facilities to increase production capacity for lancets and other critical medical devices.

Conclusion

The global lancet market was valued at USD 2.31 billion in 2025 and is expected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, supported by rising diabetes prevalence, growing home-based diagnostics, and increasing adoption of safety lancets. North America maintained market dominance, while Europe and Asia Pacific exhibited strong growth potential. Despite challenges related to cost sensitivity and limited healthcare spending in developing regions, technological advancements, safety-focused regulations, and expanding self-monitoring practices are expected to sustain market growth through 2034.

Segmentation By Type

• Standard Lancet
• Safety Lancet
• Button-activated
• Push/Top Button
• Side Button
• Pressure/Contact-activated
• Specialty Lancet

By Incision Type

• Needle
• Blade

By Age Group

• Adults
• Pediatric

By Gauge Size

• 22G and Below
• 23G-28G
• Above 28G

By Application

• Blood Glucose Monitoring
• Hemoglobin Testing
• Cholesterol Testing
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies/E-commerce Platforms

By Geography

North America (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country)

• U.S.
• Canada
• Europe (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country/Sub-region)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
• 4.2. Estimated Number of SMBG Users, By Key Countries/Region, 2025
• 4.3. Reimbursements Scenario
• 4.4. Pricing Analysis
• 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)

5. Global Lancet Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Standard Lancet
  • 5.1.2. Safety Lancet
    • 5.1.2.1. Button-activated
      • 5.1.2.1.1. Push/Top Button
      • 5.1.2.1.2. Side Button
    • 5.1.2.2. Pressure/Contact-activated
  • 5.1.3. Specialty Lancet
• 5.2. Market Analysis, Insights and Forecast - By Incision Type
  • 5.2.1. Needle
  • 5.2.2. Blade
• 5.3. Market Analysis, Insights and Forecast - By Age Group
  • 5.3.1. Adults
  • 5.3.2. Pediatric
• 5.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 5.4.1. 22G and Below
  • 5.4.2. 23G-28G
  • 5.4.3. Above 28G
• 5.5. Market Analysis, Insights and Forecast - By Application
  • 5.5.1. Blood Glucose Monitoring
  • 5.5.2. Hemoglobin Testing
  • 5.5.3. Cholesterol Testing
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.6.1. Hospital Pharmacies
  • 5.6.2. Retail Pharmacies
  • 5.6.3. Online Pharmacies
• 5.7. Market Analysis, Insights and Forecast - By Region
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. Asia Pacific
  • 5.7.4. Latin America
  • 5.7.5. Middle East & Africa

6. North America Lancet Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Standard Lancet
  • 6.1.2. Safety Lancet
    • 6.1.2.1. Button-activated
      • 6.1.2.1.1. Push/Top Button
      • 6.1.2.1.2. Side Button
    • 6.1.2.2. Pressure/Contact-activated
  • 6.1.3. Specialty Lancet
• 6.2. Market Analysis, Insights and Forecast - By Incision Type
  • 6.2.1. Needle
  • 6.2.2. Blade
• 6.3. Market Analysis, Insights and Forecast - By Age Group
  • 6.3.1. Adults
  • 6.3.2. Pediatric
• 6.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 6.4.1. 22G and Below
  • 6.4.2. 23G-28G
  • 6.4.3. Above 28G
• 6.5. Market Analysis, Insights and Forecast - By Application
  • 6.5.1. Blood Glucose Monitoring
  • 6.5.2. Hemoglobin Testing
  • 6.5.3. Cholesterol Testing
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.6.1. Hospital Pharmacies
  • 6.6.2. Retail Pharmacies
  • 6.6.3. Online Pharmacies
• 6.7. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.7.1. U.S.
  • 6.7.2. Canada

7. Europe Lancet Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Standard Lancet
  • 7.1.2. Safety Lancet
    • 7.1.2.1. Button-activated
      • 7.1.2.1.1. Push/Top Button
      • 7.1.2.1.2. Side Button
    • 7.1.2.2. Pressure/Contact-activated
  • 7.1.3. Specialty Lancet
• 7.2. Market Analysis, Insights and Forecast - By Incision Type
  • 7.2.1. Needle
  • 7.2.2. Blade
• 7.3. Market Analysis, Insights and Forecast - By Age Group
  • 7.3.1. Adults
  • 7.3.2. Pediatric
• 7.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 7.4.1. 22G and Below
  • 7.4.2. 23G-28G
  • 7.4.3. Above 28G
• 7.5. Market Analysis, Insights and Forecast - By Application
  • 7.5.1. Blood Glucose Monitoring
  • 7.5.2. Hemoglobin Testing
  • 7.5.3. Cholesterol Testing
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.6.1. Hospital Pharmacies
  • 7.6.2. Retail Pharmacies
  • 7.6.3. Online Pharmacies
• 7.7. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.7.1. U.K.
  • 7.7.2. Germany
  • 7.7.3. France
  • 7.7.4. Spain
  • 7.7.5. Italy
  • 7.7.6. Scandinavia
  • 7.7.7. Rest of Europe

8. Asia pacific Lancet Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Standard Lancet
  • 8.1.2. Safety Lancet
    • 8.1.2.1. Button-activated
      • 8.1.2.1.1. Push/Top Button
      • 8.1.2.1.2. Side Button
    • 8.1.2.2. Pressure/Contact-activated
  • 8.1.3. Specialty Lancet
• 8.2. Market Analysis, Insights and Forecast - By Incision Type
  • 8.2.1. Needle
  • 8.2.2. Blade
• 8.3. Market Analysis, Insights and Forecast - By Age Group
  • 8.3.1. Adults
  • 8.3.2. Pediatric
• 8.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 8.4.1. 22G and Below
  • 8.4.2. 23G-28G
  • 8.4.3. Above 28G
• 8.5. Market Analysis, Insights and Forecast - By Application
  • 8.5.1. Blood Glucose Monitoring
  • 8.5.2. Hemoglobin Testing
  • 8.5.3. Cholesterol Testing
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.6.1. Hospital Pharmacies
  • 8.6.2. Retail Pharmacies
  • 8.6.3. Online Pharmacies
• 8.7. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.7.1. Japan
  • 8.7.2. China
  • 8.7.3. India
  • 8.7.4. Australia
  • 8.7.5. South Korea
  • 8.7.6. Southeast Asia
  • 8.7.7. Rest of Asia Pacific

9. Latin America Lancet Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Standard Lancet
  • 9.1.2. Safety Lancet
    • 9.1.2.1. Button-activated
      • 9.1.2.1.1. Push/Top Button
      • 9.1.2.1.2. Side Button
    • 9.1.2.2. Pressure/Contact-activated
  • 9.1.3. Specialty Lancet
• 9.2. Market Analysis, Insights and Forecast - By Incision Type
  • 9.2.1. Needle
  • 9.2.2. Blade
• 9.3. Market Analysis, Insights and Forecast - By Age Group
  • 9.3.1. Adults
  • 9.3.2. Pediatric
• 9.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 9.4.1. 22G and Below
  • 9.4.2. 23G-28G
  • 9.4.3. Above 28G
• 9.5. Market Analysis, Insights and Forecast - By Application
  • 9.5.1. Blood Glucose Monitoring
  • 9.5.2. Hemoglobin Testing
  • 9.5.3. Cholesterol Testing
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.6.1. Hospital Pharmacies
  • 9.6.2. Retail Pharmacies
  • 9.6.3. Online Pharmacies
• 9.7. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.7.1. Brazil
  • 9.7.2. Mexico
  • 9.7.3. Rest of Latin America

10. Middle East & Africa Lancet Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Standard Lancet
  • 10.1.2. Safety Lancet
    • 10.1.2.1. Button-activated
      • 10.1.2.1.1. Push/Top Button
      • 10.1.2.1.2. Side Button
    • 10.1.2.2. Pressure/Contact-activated
  • 10.1.3. Specialty Lancet
• 10.2. Market Analysis, Insights and Forecast - By Incision Type
  • 10.2.1. Needle
  • 10.2.2. Blade
• 10.3. Market Analysis, Insights and Forecast - By Age Group
  • 10.3.1. Adults
  • 10.3.2. Pediatric
• 10.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 10.4.1. 22G and Below
  • 10.4.2. 23G-28G
  • 10.4.3. Above 28G
• 10.5. Market Analysis, Insights and Forecast - By Application
  • 10.5.1. Blood Glucose Monitoring
  • 10.5.2. Hemoglobin Testing
  • 10.5.3. Cholesterol Testing
  • 10.5.4. Others
• 10.6. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.6.1. Hospital Pharmacies
  • 10.6.2. Retail Pharmacies
  • 10.6.3. Online Pharmacies
• 10.7. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.7.1. GCC
  • 10.7.2. South Africa
  • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.2.1. BD
  • 11.2.2. SARSTEDT AG & Co. KG
  • 11.2.3. Greiner Bio-One International GmbH
  • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
  • 11.2.5. Terumo Medical Corporation
  • 11.2.6. B. Braun SE
  • 11.2.7. Abbott
  • 11.2.8. Cardinal Health
  • 11.2.9. YPSOMED
  • 11.2.10. Medline Industries, LP.
  • 11.2.11. Biosense Technologies Private Limited